| Authors: |
Silverberg JI; Department of Dermatology, George Washington University School of Medicine and Health Sciences, Washington, District of Columbia., Eichenfield LF; Departments of Dermatology and Pediatrics, University of California San Diego School of Medicine, La Jolla, California., Armstrong AW; Division of Dermatology, University of California Los Angeles, Los Angeles, California., Bagel J; Director Eczema Center of New Jersey, Clinical Professor of Dermatology at The Icahn School of Medicine at Mount Sinai, East Windsor, New Jersey., Lockshin B; US Dermatology Partners, Rockville, Maryland., Boh E; Department of Dermatology, Tulane University School of Medicine, New Orleans, Louisiana., Koo J; Department of Dermatology, University of California, San Francisco School of Medicine, San Francisco, California., Farberg AS; Baylor Scott & White Health System, Dallas, Texas; Bare Dermatology, Dallas, Texas., Goldberg MS; Research & Development, Castle Biosciences, Inc., Friendswood, Texas; Medical Affairs, Castle Biosciences, Inc., Friendswood, Texas; Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: mgoldberg@castlebiosciences.com., Quick AP; Research & Development, Castle Biosciences, Inc., Friendswood, Texas., Lebwohl MG; Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York. |
